About the Founder – Dr. Hayder Mazin, MBChB
Founder & CEO of AORTA | Medical Doctor | Global Heart Health Advocate

Dr. Hayder Mazin, MBChB, is a physician, medical entrepreneur, and medical communication strategist dedicated to advancing global cardiovascular health through education, prevention, and ethical knowledge dissemination.
He is the Founder and Chief Executive Officer of AORTA, a heart-health education platform built on scientific rigor, transparency, and public empowerment, and MedLexis, a medical writing and content strategy consultancy serving healthcare organizations worldwide.
With a unique blend of clinical training, medical writing expertise, and digital health leadership, Dr. Mazin has established himself as a trusted voice in preventive cardiology and evidence-based health communication.
Professional Background & Medical Foundation
Dr. Mazin earned his Bachelor of Medicine, Bachelor of Surgery (MBChB) degree from the University of Diyala, College of Medicine, graduating in 2024. His medical training provided him with a strong foundation in evidence-based clinical practice, patient-centered care, and preventive medicine.
Beyond clinical medicine, Dr. Mazin pursued specialized training in medical writing, research synthesis, health education, translation, and digital medical communication, enabling him to bridge the gap between complex scientific literature and public understanding.
This dual expertise forms the cornerstone of his work across AORTA and MedLexis.
Founder & CEO — AORTA
Global Heart Health Education Platform
Founded by Dr. Mazin, AORTA was created to address a critical global challenge: the widespread lack of accessible, accurate, and trustworthy cardiovascular health information.
Under his leadership, AORTA has:
- Published 225+ evidence-based heart health articles covering cardiovascular diseases, risk factors, prevention, treatment, and rehabilitation
- Built a multi-physician editorial and medical review board operating under strict E-E-A-T principles
- Established a rigorous editorial system aligned with international standards (AHA, WHO, NIH)
- Prioritized prevention-first education, empowering individuals to reduce cardiovascular risk through informed lifestyle choices
- Integrated ethical AI tools to enhance accuracy, efficiency, and scalability without compromising medical integrity
Dr. Mazin personally leads AORTA’s editorial strategy, quality assurance, and medical accuracy oversight, ensuring every published resource meets the highest standards of scientific validity and public trust.
Founder & CEO — MedLexis
Medical Writing & Content Strategy Consultancy
In parallel with AORTA, Dr. Mazin founded MedLexis, a professional medical writing and content solutions provider serving healthcare platforms, clinicians, startups, and medical organizations.
Through MedLexis, he has:
- Delivered high-quality medical writing services, including patient education materials, clinical articles, and digital health content
- Supported healthcare brands in translating scientific evidence into clear, compliant, and engaging communication
- Applied AI-assisted workflows responsibly to improve productivity while maintaining editorial precision
- Led multidisciplinary teams of medical writers and reviewers to ensure consistency, accuracy, and ethical standards
MedLexis reflects Dr. Mazin’s broader mission: to elevate the quality of medical information available to both professionals and the public.
Thought Leadership & Vision
Dr. Mazin is a strong advocate for prevention-focused cardiovascular care, believing that most heart disease is preventable through early awareness, lifestyle optimization, and evidence-based guidance. His work emphasizes:
- Public empowerment through education
- Ethical medical communication
- Digital innovation in healthcare knowledge delivery
- Global accessibility, particularly for underserved populations
His long-term vision for AORTA is to become a globally recognized authority in heart health education, reaching millions of readers annually and contributing meaningfully to the reduction of cardiovascular disease burden worldwide.
Core Expertise
- Preventive Cardiology & Cardiovascular Risk Education
- Medical Writing & Evidence-Based Communication
- Editorial Leadership & Quality Governance
- Digital Health Strategy & SEO-Driven Medical Content
- Ethical Use of AI in Medical Publishing
- Health Education & Public Awareness Campaigns
Commitment to Ethics & Accuracy
Dr. Mazin operates under strict ethical principles. All content produced under his leadership adheres to:
- Evidence-based medical guidelines
- Transparent sourcing and medical review
- Clear separation between education and medical advice
- Continuous updating as scientific knowledge evolves
This commitment underpins AORTA’s reputation as a trusted, medically responsible heart health platform.
Philosophy & Vision
“Cardiovascular disease is largely preventable. My mission is to ensure that accurate, evidence-based knowledge is no longer a privilege, but a right—accessible to every individual, in every community, at the right time.”
— Dr. Hayder Mazin, MBChB
This philosophy guides Dr. Mazin’s work across AORTA and MedLexis, shaping a prevention-first approach grounded in scientific integrity, ethical communication, and public empowerment.
Publications & Editorial Contributions
Dr. Hayder Mazin is the primary author, senior medical reviewer, and editorial lead for AORTA’s cardiovascular education platform. His work spans the full spectrum of heart health, from risk-factor awareness to advanced prevention strategies.
Key Contributions at AORTA:
- Authored and reviewed 150+ evidence-based articles on cardiovascular disease, prevention, lifestyle optimization, and rehabilitation
- Led the development of AORTA’s editorial and medical review standards, aligned with AHA, WHO, and NIH guidance
- Personally oversees content accuracy, updates, and ethical compliance across all published materials
All publications under Dr. Mazin’s leadership are designed to translate complex medical evidence into clear, actionable, and medically responsible education for the public and healthcare audiences alike.
Artificial Intelligence in Cardiology: Transforming Diagnosis and Care
Cardiovascular disease (CVD) remains the leading cause of death globally, necessitating continuous innovation in diagnosis, prediction, and treatment strategies. The...
Read MorePersonalized Medicine in Cardiology: The Future of Your Heart Health
Personalized medicine in cardiology is marking a revolutionary shift away from the traditional “one-size-fits-all” approach to treating heart disease. For...
Read MoreDigital Health for Heart Disease Prevention: A Modern Guide
Cardiovascular disease (CVD) remains the leading cause of death globally. This staggering statistic highlights the persistent challenge of managing risk...
Read MoreAlternative Therapies for Heart Health: What the Science Says
The pursuit of a healthier heart often leads people beyond traditional medicine and toward alternative therapies for heart health. These...
Read MoreCardio-Oncology: Protecting the Heart During and After Cancer Treatment
The remarkable advancements in cancer therapy have dramatically increased the survival rates for millions of patients worldwide. However, this success...
Read MorePost Heart Attack Care: Your Step-by-Step Guide to Recovery
A heart attack, or myocardial infarction (MI), is a life-changing event. It marks not an ending, but the beginning of...
Read MoreAHA Life’s Essential 8: Comprehensive Cardiovascular Prevention Framework
Abstract The American Heart Association’s Life’s Essential 8 (LE8) represents a comprehensive, updated cardiovascular prevention framework for assessing and promoting...
Read MoreInfective Endocarditis Management: ESC/AHA 2023 Guidelines
Abstract Infective endocarditis (IE) remains a severe microbial infection of the endocardium with high morbidity and mortality, necessitating rapid, guideline-driven...
Read MoreESC 2023 Valvular Heart Disease Guidelines: Key Decisions & Intervention Timing
Abstract The 2023 European Society of Cardiology (ESC) Guidelines for the management of Valvular Heart Disease (VHD) present significant updates...
Read MoreCardio-Kidney-Metabolic Syndrome: ACC CKM Staging & Management
Abstract This article reviews the clinical implications of the Cardio-Kidney-Metabolic (CKM) Syndrome continuum, focusing on the 2023 American College of...
Read MoreKDIGO 2024 CKD Guidelines: A Framework for Cardiorenal Integration
Abstract The KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease (CKD) represents a pivotal...
Read MoreADA 2024 Standards of Care: Cardiorenal Protection Updates
Abstract The 2024 updates to the American Diabetes Association (ADA) Standards of Care reflect a paradigm shift from purely glycemic...
Read MoreACC/AHA 2023 Lipid Management: Risk-Based Strategy, Lp(a), and apoB
Abstract The ACC/AHA 2023 lipid management guidelines consolidate the risk-based approach to atherosclerotic cardiovascular disease (ASCVD) prevention while integrating novel...
Read MoreESC 2023 Dyslipidemia: New LDL-C Targets & Non-Statin Rx
Abstract The European Society of Cardiology (ESC) 2023 Guidelines for the Management of Dyslipidaemias represent a significant intensification of therapeutic...
Read MoreHypertension in Pregnancy: Current ESC Standards & Evolving Evidence
Abstract Objective: Hypertensive disorders of pregnancy (HDP), including preeclampsia and chronic hypertension, remain a dominant cause of maternal and neonatal...
Read MoreLatest AHA/ACC Hypertension Guidelines: CKM Integration & Comorbidity Targets
Abstract This article summarizes the Latest AHA/ACC Hypertension Guidelines, focusing on critical updates for clinical practice, particularly the integration of...
Read MoreESC/ESH 2023 Hypertension Guidelines: Key Updates on Targets and Therapy
Abstract The 2023 Guidelines for the management of arterial hypertension, co-published by the European Society of Cardiology (ESC) and the...
Read MoreSVT Catheter Ablation: Indications, Outcomes, and Monitoring
Abstract Catheter ablation has emerged as the definitive, first-line therapeutic strategy for many forms of supraventricular tachycardia (SVT), shifting the...
Read More2023 Bradyarrhythmias Pacing Guidelines: Key Indications and Protocols
Abstract The management of bradyarrhythmias and cardiac conduction disorders is continuously refined by evidence from major clinical trials, necessitating regular...
Read More2023 Ventricular Arrhythmia Guidelines: Key Updates on ICD and Prevention
Abstract The 2023 AHA/ACC/HRS Guideline for the Management of Patients With Ventricular Arrhythmias (VA) and the Prevention of Sudden Cardiac...
Read MoreESC 2024 Atrial Fibrillation Guidelines: Stroke Prevention and Rhythm Control
Abstract This review summarizes the critical updates and clinical implications derived from the 2024 European Society of Cardiology (ESC) Guidelines...
Read MoreCardiac Transplantation and Mechanical Circulatory Support in Advanced HF
Abstract Advanced heart failure (AHF), refractory to guideline-directed medical therapy (GDMT), represents a critical clinical challenge with high morbidity and...
Read MoreCardiomyopathy Review: 2023 ESC Guidelines & AHA/ACC Classification and Management
Abstract Cardiomyopathies are a heterogeneous group of disorders associated with structural and functional abnormalities of the myocardium, leading to potentially...
Read MoreAcute Decompensated Heart Failure Management: Guideline-Driven Strategy
Abstract Acute decompensated heart failure (ADHF) is a leading cause of hospitalization with high morbidity and mortality, necessitating rapid, evidence-based...
Read More






















